Get started
Author

Jenna-Marie Dix

Observed name: Jenna-marie Dix
ORCID: 0000-0001-8822-4049
Observed ORCID: 0000-0001-8822-4049
OpenAlex ID: A5014777471
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
2021 · A. Rose Brannon, Gowtham Jayakumaran, et al. · Nature Communications · 174
PDF
HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
2024 · Tom Zhang, Christopher A. Febres-Aldana, et al. · Clinical Cancer Research · 23
PDF
Enhanced specificity of high sensitivity somatic variant profiling in cell-free DNA via paired normal sequencing: design, validation, and clinical experience of the MSK-ACCESS liquid biopsy assay
2020 · A. Rose Brannon, Gowtham Jayakumaran, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7
PDF
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al. · Clinical Cancer Research · 3
PDF
Supplementary Data2 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data3 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Data from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data6 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data1 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data5 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Supplementary Data4 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026 · Alexander J. Pfeil, Tom Zhang, et al.
Data from HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
2024 · Tom Zhang, Christopher A. Febres-Aldana, et al.
Supplementary Table S1 from HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
2024 · Tom Zhang, Christopher A. Febres-Aldana, et al.
Supplementary Figures 1 from HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
2024 · Tom Zhang, Christopher A. Febres-Aldana, et al.
Supplementary Table S2 from HER2 Antibody–Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor
2024 · Tom Zhang, Christopher A. Febres-Aldana, et al.
Abstract PR08: Validation and clinical implementation of MSK-ACCESS, an ultra-deep sequencing assay for noninvasive somatic mutation profiling
2020 · A. Rose Brannon, Gowtham Jayakumaran, et al. · Clinical Cancer Research
Works count: 16
Citation count: 206
H-index: 3
I10-index: 2
Year
Topic
Type